Skip to content
healthcare.dev

Purpose Dual Treatment SPF 10

NDC 87033-2000, Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%, lotion, from Elysium Consumer Healthcare LLC.

Product NDC
87033-2000
Status
Listed
Labeler
Elysium Consumer Healthcare LLC
Dosage form
LOTION
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87033-2000 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBENZONE3 g/100g
  • OCTINOXATE7.5 g/100g
  • OCTISALATE5 g/100g
Package NDCNDC-11Package
87033-2000-1870332000011 BOTTLE, PLASTIC in 1 CARTON (87033-2000-1) / 113 g in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87033-2000 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87033-2000 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87033-2000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.